show timeout overlay link

Your Session Is About to Expire

This online session is about to expire due to inactivity. Click Continue to return to page.

  • myWeekly Ad

Levsin: Oral tablet

Also see:
  • Reported side effects
  • Daily life interactions

Available Strengths
Drug Image file DrugItem_10206.JPG
Levsin 0.125mg Tab
Meda Pharmaceuticals formerly Alaven Pharmaceuticals LLC
Pill Identification: SCHWARZ  |  531
Drug Image file DrugItem_1943.JPG
Levsin 0.125mg Tab
Meda Pharmaceuticals formerly Alaven Pharmaceuticals LLC
Pill Identification: SCHWARZ  |  531
Drug Image file DrugItem_13113.JPG
Levsin 0.125mg Tab
Meda Pharmaceuticals formerly Alaven Pharmaceuticals LLC
Pill Identification: AP  |  112

Frequently Asked Questions (FAQs) on Levsin: Oral tablet

What is this medicine?

HYOSCYAMINE (hye oh SYE a meen) is used to treat stomach and bladder problems. It is also used for rhinitis, to reduce some problems caused by Parkinson's disease, and for the treatment of poisoning with drugs that are usually used to treat myasthenia gravis.

Similar Brand Name Drugs : Cystospaz: Oral tablet  |  Anaspaz: Oral tablet

Similar Generic Drugs : Hyoscyamine Sulfate: Oral tablet

What should I tell my health care provider before I take this medicine?

How should I use this medicine?

What if I miss a dose?

What may interact with this medicine?

What should I watch for while using this medicine?

What side effects may I notice from receiving this medicine?

Where should I keep my medicine?

Drugs Related by Class to Levsin: Oral tablet
In-Depth Information on This Drug
Select a specific strength to visit the detail page where you'll find :
  • Reported side effects
  • Daily life interactions
Select a Strength
Patient Experiences with Levsin

We want to help you stay educated about the medications you are taking. View other
patient's observations and share your own.

Be sure to consult your health care provider before taking any medications. Other
patient's comments should not be considered medical advice or health care provider
recommendations.